Becton Dickinson & Co
BOX
Company Profile
Business description
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Contact
1 Becton Drive
Franklin LakesNJ07417-1880
USAT: +1 201 847-6800
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2027
Employees
72,000
Stocks News & Analysis
stocks
Anthropic and OpenAI face commodification threats. Here’s what to watch for
Frontier AI labs face a three-pronged set of challenges.
stocks
Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment
We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,975.70 | 35.30 | 0.39% |
| CAC 40 | 7,845.50 | 111.20 | -1.40% |
| DAX 40 | 25,324.17 | 298.44 | -1.16% |
| Dow JONES (US) | 52,002.41 | 175.28 | -0.34% |
| FTSE 100 | 10,778.11 | 103.79 | -0.95% |
| HKSE | 24,186.83 | 124.11 | 0.52% |
| NASDAQ | 26,140.03 | 572.99 | -2.14% |
| Nikkei 225 | 64,916.70 | 407.59 | -0.62% |
| NZX 50 Index | 13,652.07 | 101.66 | -0.74% |
| S&P 500 | 7,659.44 | 84.62 | -1.09% |
| S&P/ASX 200 | 8,845.70 | 39.00 | 0.44% |
| SSE Composite Index | 3,716.28 | 8.81 | 0.24% |